135 related articles for article (PubMed ID: 37364397)
1. ZLDI-8 suppresses angiogenesis and vasculogenic mimicry in drug-resistant NSCLC in vitro and in vivo.
Lu H; Wu C; Jiang XW; Zhao Q
Lung Cancer; 2023 Aug; 182():107279. PubMed ID: 37364397
[TBL] [Abstract][Full Text] [Related]
2. Luteolin suppresses angiogenesis and vasculogenic mimicry formation through inhibiting Notch1-VEGF signaling in gastric cancer.
Zang M; Hu L; Zhang B; Zhu Z; Li J; Zhu Z; Yan M; Liu B
Biochem Biophys Res Commun; 2017 Aug; 490(3):913-919. PubMed ID: 28655612
[TBL] [Abstract][Full Text] [Related]
3. Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo.
Lu HY; Zu YX; Jiang XW; Sun XT; Liu TY; Li RL; Wu Q; Zhang YS; Zhao QC
Pharmacol Res; 2019 Oct; 148():104406. PubMed ID: 31442576
[TBL] [Abstract][Full Text] [Related]
4. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer.
Fan X; Huang J; Hu B; Zhou J; Chen L
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8729-8741. PubMed ID: 37129607
[TBL] [Abstract][Full Text] [Related]
5. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
Li X; Wang X; Ye H; Peng A; Chen L
Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
[TBL] [Abstract][Full Text] [Related]
6. Luteolin Suppresses Three Angiogenesis Modes and Cell Interaction in Uveal Melanoma
Chen YF; Wu S; Li X; Chen M; Liao HF
Curr Eye Res; 2022 Dec; 47(12):1590-1599. PubMed ID: 36214596
[TBL] [Abstract][Full Text] [Related]
7. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo.
Lu HY; Chu HX; Tan YX; Qin XC; Liu MY; Li JD; Ren TS; Zhang YS; Zhao QC
Life Sci; 2020 Mar; 244():117343. PubMed ID: 31978449
[TBL] [Abstract][Full Text] [Related]
8. The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms.
Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Li ZY; Zhang RG; Zhu F; Wu G
Int J Cancer; 2019 May; 144(9):2227-2238. PubMed ID: 30374974
[TBL] [Abstract][Full Text] [Related]
9. An-te-xiao capsule inhibits tumor growth in non-small cell lung cancer by targeting angiogenesis.
Han L; Wang JN; Cao XQ; Sun CX; Du X
Biomed Pharmacother; 2018 Dec; 108():941-951. PubMed ID: 30372906
[TBL] [Abstract][Full Text] [Related]
10. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
Shi J; Lu Y; Wei P
J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
[TBL] [Abstract][Full Text] [Related]
11. COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling.
Jue C; Min Z; Zhisheng Z; Lin C; Yayun Q; Xuanyi W; Feng J; Haibo W; Youyang S; Tadashi H; Shintaro I; Shiyu G; Yanqing L
J Ethnopharmacol; 2017 Aug; 208():165-173. PubMed ID: 28694103
[TBL] [Abstract][Full Text] [Related]
12. The antiparasitic drug, potassium antimony tartrate, inhibits tumor angiogenesis and tumor growth in nonsmall-cell lung cancer.
Wang B; Yu W; Guo J; Jiang X; Lu W; Liu M; Pang X
J Pharmacol Exp Ther; 2015 Jan; 352(1):129-38. PubMed ID: 25352499
[TBL] [Abstract][Full Text] [Related]
13. Honokiol inhibits interleukin-induced angiogenesis in the NSCLC microenvironment through the NF-κB signaling pathway.
Cheng X; Wang F; Qiao Y; Chen T; Fan L; Shen X; Yu D; Huang Y; Wei M
Chem Biol Interact; 2023 Jan; 370():110295. PubMed ID: 36470525
[TBL] [Abstract][Full Text] [Related]
14. A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.
Lien JC; Chung CL; Huang TF; Chang TC; Chen KC; Gao GY; Hsu MJ; Huang SW
Br J Pharmacol; 2019 Oct; 176(20):4034-4049. PubMed ID: 31368127
[TBL] [Abstract][Full Text] [Related]
15. PP2A regulates metastasis and vasculogenic mimicry formation via PI3K/AKT/ZEB1 axis in non-small cell lung cancers.
Zhang Y; Wang X; Li A; Guan Y; Shen P; Ni Y; Han X
J Pharmacol Sci; 2022 Oct; 150(2):56-66. PubMed ID: 36055752
[TBL] [Abstract][Full Text] [Related]
16. Human apurinic/apyrimidinic endonuclease siRNA inhibits the angiogenesis induced by X-ray irradiation in lung cancer cells.
Gu X; Cun Y; Li M; Qing Y; Jin F; Zhong Z; Dai N; Qian C; Sui J; Wang D
Int J Med Sci; 2013; 10(7):870-82. PubMed ID: 23781133
[TBL] [Abstract][Full Text] [Related]
17. RPV-modified epirubicin and dioscin co-delivery liposomes suppress non-small cell lung cancer growth by limiting nutrition supply.
Kong L; Cai FY; Yao XM; Jing M; Fu M; Liu JJ; He SY; Zhang L; Liu XZ; Ju RJ; Li XT
Cancer Sci; 2020 Feb; 111(2):621-636. PubMed ID: 31777993
[TBL] [Abstract][Full Text] [Related]
18. DHPAC, a novel microtubule depolymerizing agent, suppresses angiogenesis and vasculogenic mimicry formation of human non-small cell lung cancer.
Gong FL; Wang L; Yu LG; Dang YF; Jiang XN; Zhao L; Guo XL
J Cell Biochem; 2020 Dec; 121(12):4756-4771. PubMed ID: 32056279
[TBL] [Abstract][Full Text] [Related]
19. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer.
Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y
Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Aquaporin 1-Inhibition on Vasculogenic Mimicry in Malignant Mesothelioma.
Pulford E; McEvoy J; Hocking A; Prabhakaran S; Griggs K; Klebe S
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
